Considering the promising efficacy of immunotherapy, especially inhibitors of immune checkpoints such as PD-1 and PD-L1, in multiple malignancies including GC, we further evaluated the predictive role of MEMTS in KIM cohort and Hugo cohort. The gene discussed is PDCD1; the disease is gastric cancer.